- Home
- ITRM vs NRT Comparison
ITRM vs NRT Comparison
Compare ITRM & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- NRT
- Stock Information
- Founded
- ITRM 2015
- NRT 1975
- Country
- ITRM Ireland
- NRT United States
- Employees
- ITRM N/A
- NRT N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- NRT Oil & Gas Production
- Sector
- ITRM Health Care
- NRT Energy
- Exchange
- ITRM Nasdaq
- NRT Nasdaq
- Market Cap
- ITRM 40.0M
- NRT 46.4M
- IPO Year
- ITRM 2018
- NRT N/A
- Fundamental
- Price
- ITRM $0.82
- NRT $5.05
- Analyst Decision
- ITRM Strong Buy
- NRT
- Analyst Count
- ITRM 2
- NRT 0
- Target Price
- ITRM $7.00
- NRT N/A
- AVG Volume (30 Days)
- ITRM 751.2K
- NRT 19.8K
- Earning Date
- ITRM 08-13-2025
- NRT 08-29-2025
- Dividend Yield
- ITRM N/A
- NRT 9.29%
- EPS Growth
- ITRM N/A
- NRT 24.05
- EPS
- ITRM N/A
- NRT 0.59
- Revenue
- ITRM N/A
- NRT $6,184,173.00
- Revenue This Year
- ITRM N/A
- NRT N/A
- Revenue Next Year
- ITRM $270.19
- NRT N/A
- P/E Ratio
- ITRM N/A
- NRT $8.88
- Revenue Growth
- ITRM N/A
- NRT 18.55
- 52 Week Low
- ITRM $0.81
- NRT $3.88
- 52 Week High
- ITRM $3.02
- NRT $6.77
- Technical
- Relative Strength Index (RSI)
- ITRM 35.21
- NRT 57.33
- Support Level
- ITRM $0.81
- NRT $4.65
- Resistance Level
- ITRM $0.90
- NRT $5.03
- Average True Range (ATR)
- ITRM 0.08
- NRT 0.19
- MACD
- ITRM -0.02
- NRT 0.03
- Stochastic Oscillator
- ITRM 4.46
- NRT 79.37
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.